» Articles » PMID: 20551985

Antibiotic Discovery in the Twenty-first Century: Current Trends and Future Perspectives

Overview
Date 2010 Jun 17
PMID 20551985
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

New antibiotics are necessary to treat microbial pathogens that are becoming increasingly resistant to available treatment. Despite the medical need, the number of newly approved drugs continues to decline. We offer an overview of the pipeline for new antibiotics at different stages, from compounds in clinical development to newly discovered chemical classes. Consistent with historical data, the majority of antibiotics under clinical development are natural products or derivatives thereof. However, many of them also represent improved variants of marketed compounds, with the consequent risk of being only partially effective against the prevailing resistance mechanisms. In the discovery arena, instead, compounds with promising activities have been obtained from microbial sources and from chemical modification of antibiotic classes other than those in clinical use. Furthermore, new natural product scaffolds have also been discovered by ingenious screening programs. After providing selected examples, we offer our view on the future of antibiotic discovery.

Citing Articles

More evolvable bacteriophages better suppress their host.

Horwitz E, Strobel H, Haiso J, Meyer J Evol Appl. 2024; 17(7):e13742.

PMID: 38975285 PMC: 11224127. DOI: 10.1111/eva.13742.


Diversity and antimicrobial activity of the tropical ant-derived actinomycetes isolated from Thailand.

Tunvongvinis T, Jaitrong W, Samung Y, Tanasupawat S, Phongsopitanun W AIMS Microbiol. 2024; 10(1):68-82.

PMID: 38525037 PMC: 10955170. DOI: 10.3934/microbiol.2024005.


Naphthyl-Substituted Indole and Pyrrole Carboxylic Acids as Effective Antibiotic Potentiators-Inhibitors of Bacterial Cystathionine γ-Lyase.

Kuzovlev A, Zybalov M, Golovin A, Gureev M, Kasatkina M, Biryukov M Int J Mol Sci. 2023; 24(22).

PMID: 38003521 PMC: 10671052. DOI: 10.3390/ijms242216331.


Sub-MIC streptomycin and tetracycline enhanced Guangzhou-SAU749 biofilm formation, an in-depth study on transcriptomics.

Liu J, Huang T, Xu Z, Mao Y, Soteyome T, Liu G Biofilm. 2023; 6:100156.

PMID: 37779859 PMC: 10539642. DOI: 10.1016/j.bioflm.2023.100156.


Whole genome analysis of sp. RerS4, a rhizosphere microbe producing a new lipopeptide.

He H, Huang J, Zhao Z, Du P, Li J, Xin J Heliyon. 2023; 9(9):e19543.

PMID: 37681179 PMC: 10480658. DOI: 10.1016/j.heliyon.2023.e19543.